Amalian

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amalian

Property Description
Active ingredient Sodium Hyaluronate (Hyaluronic Acid)
Form Injectable Gel (Jelly) / Highly Viscous Solution
Pharmacological Class Dermal Filler, Viscoelastic Agent, Aesthetic Medicine Product
General Purpose Volume Restoration and Structural Support in Soft Tissues
Origin Non-animal derived, bio-fermentative source

Amalian: Classification and Core Composition

Amalian is classified as an Injectable Gel within the specialized medical device category of a Dermal Filler and Viscoelastic Agent, utilized for aesthetic soft tissue augmentation. The active compound is highly purified Sodium Hyaluronate (Hyaluronic Acid), a polysaccharide and glycosaminoglycan naturally abundant in human connective tissues. The Hyaluronic Acid used in these preparations is typically non-animal derived, produced through controlled bio-fermentation processes to ensure a high level of purity. The primary mechanism of such fillers is to replace lost tissue volume, imparting a fuller appearance to skin that has lost its elasticity. This function is based on the material's physical properties as a volume replacement tool.

The Unique Form of the Hyaluronic Acid Gel

The product is supplied as a sterile, highly viscous Injectable Gel that features specially stabilized, cross-linked hyaluronic acid to prevent rapid breakdown within the body. This cross-linking process is essential as non-cross-linked HA is degraded rapidly in vivo. The Amalian brand is distinct due to its specialized polymer characteristics, often differentiating its product lines as either monophasic or biphasic, where the latter may utilize the Core-in-Shell system. This engineering of the Injectable Gel is recognized for balancing high lifting capacity with smooth tissue integration, making it specifically suited for stable dermal implantation.

General Purpose in Aesthetic Medicine

The general purpose of Amalian is the immediate Volume Restoration and provision of Structural Support in soft tissues, which is the core of its function in Aesthetic Medicine. The high viscoelasticity of the specialized Sodium Hyaluronate gel allows it to act as a scaffold. This function enables general aesthetic applications such as the enhancement of facial contours and the improvement of the appearance of deep facial wrinkles and folds. The safety and effectiveness of Hyaluronic Acid fillers contribute to their widespread use in aesthetic procedures. The material is recognized for its bio-compatibility and reliable performance as an augmentation tool.

Regulatory References

  1. NIH, PMC10413051
  2. NIH, PMC11479139

What side effects are possible with Amalian?

Possible Side Effects and Safety Information

The official safety profile for Amalian, a Sodium Hyaluronate Injectable Gel, details adverse reactions that are primarily related to the injection procedure and the physical presence of the viscoelastic gel. This information is classified by regulatory agencies, such as the FDA and EMA, across several System-Organ Classes.

Adverse Reaction Classification

Category Common Reactions Rare/Serious Reactions
General Disorders Swelling (Edema), Redness (Erythema), Pain, Tenderness, Bruising (Ecchymosis), Itching (Pruritus) at the injection site. Severe Hypersensitivity (Anaphylaxis), Necrosis (Tissue Death)
Skin & Subcutaneous Tissue Firmness (Induration), Small Lumps/Bumps (Papules or Nodules) Granulomas (severe, delayed inflammatory nodules), Discoloration (Hyperpigmentation)
Vascular Disorders Bruising Vascular Occlusion, Vision Impairment (including blindness)

Adverse events are classified by timing: Early Onset reactions, such as pain and swelling, typically resolve within days to weeks. Delayed Onset reactions, including persistent nodules or granulomas, may manifest weeks or months after administration, as documented in post-market surveillance.

Safety Restrictions and Considerations

The product is officially contraindicated for use in individuals with a known history of severe allergies or anaphylaxis, and should not be administered in areas with active skin inflammation, infection, or skin eruptions. Regulatory documents state that the safety and effectiveness of this class of product have not been established in pregnant or breastfeeding women or in pediatric patients.

Overdose and Emergency Response

Overdose and when to seek help — official regulatory information for Amalian

Overdose scope

Documented overdose presentations: Overcorrection resulting in localized lumpiness, asymmetry, contour irregularities, or the Tyndall effect (bluish discoloration). Physiological systems affected (as stated in label): Vascular system (occlusion leading to necrosis), Nervous system (vision abnormalities including blindness, stroke). Dose-related or exposure-related factors: Injection of excessive volume (overcorrection) or unintended injection into a blood vessel (vascular occlusion). Population-specific overdose notes: The product is contraindicated for use in individuals who are under 18 years of age. Emergency-response statements: Seek immediate medical attention. The enzyme Hyaluronidase is the specific procedural agent available to dissolve the product material. When immediate medical help is required (label-derived phrasing only): When experiencing unusual pain, sudden vision changes, skin discoloration (white/gray/blue appearance), or signs of a stroke.

Overdose classifications (high-level)

Severity classification (as defined in official documents): Severe outcomes are defined as life-threatening or tissue-threatening events resulting from procedural complications. Regulatory basis: FDA and EMA medical device vigilance guidance. Overdose-context constraints: Management requires specific procedural interventions based on the nature of the complication.

Resulting overdose structure

Official overdose statements:

  • Lumpiness, asymmetry, or the Tyndall effect are documented manifestations of product overcorrection.
  • Life-threatening outcomes include necrosis, blindness, and stroke following vascular compromise.
  • Urgent medical care is mandated for unusual pain, sudden vision changes, or signs of stroke.
  • The enzyme Hyaluronidase is documented as the specific procedural agent available to reverse the product.

Connection to the overall overdose profile (3 sentences): Official regulatory documents define the overdose profile for this product based on manifestations of excessive volume and the severe consequences of procedural complications. This guidance explicitly lists the life-threatening outcomes that may occur, thereby establishing the critical need for immediate emergency care. The documented profile specifies the exact symptoms that necessitate urgent medical attention, independent of any clinical interpretation or advisory recommendation.

Therapeutic Uses of Amalian

The primary role of Amalian is applied across domains where additional symptomatic support is needed to address the visible effects of aging and volume depletion. These products are commonly used to help create a smoother or fuller appearance in specific facial areas.

The injectable gel is relevant for managing symptom clusters that may become intense or disruptive, specifically pronounced volume deficits and established deep facial creases. Amalian is applied in clinical settings that involve correction of dermal atrophy and age-related lipoatrophy, which contributes to easing the appearance of deep folds on the skin's surface. This use is relevant for easing the symptoms related to deep facial wrinkles and folds, structural deficiencies like flattened cheeks, and localized needs such as lip augmentation. The treatment provides structural support that helps ease the overall symptom load.

“The application is considered relevant in contexts marked by increased discomfort or tension related to noticeable volume loss.”

Enhancing Structural Contours and Definition

The product is commonly used across conditions presenting with visible structural deficiencies. It is applied when appropriate in scenarios requiring stable, robust support to improve the appearance of balance and shape of the face. By restoring volume in these areas, Amalian supports patients during episodes of heightened discomfort related to structural appearance. This precision may assist with maintaining a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Volume Deficits Amalian supports patients during phases of increased distress or discomfort associated with age-related structural appearance.

Eligibility and Restrictions for Use

This section outlines the official population eligibility and exclusion criteria for Amalian, as documented in governmental regulatory sources. Only information directly related to who can and cannot receive the medicine is included.

Eligibility Status Population / Condition Regulatory Status
Absolute Contraindication Known hypersensitivity to the active substance (Amalian) or any of the product's excipients.
Use Prohibited Pregnancy and breastfeeding women; the drug can cause fetal harm, and breastfeeding must be discontinued during treatment and for a specified period after the final dose (e.g., 3 months).
Use Not Established The pediatric population (under 18 years of age); safety and efficacy have not been demonstrated in children or adolescents.
Conditional Use / Caution Patients with severe renal impairment or moderate to severe hepatic impairment require caution as insufficient clinical data are available for these groups.

The medicine is restricted to adult patients with a specific confirmed genetic marker as determined by an approved test. Eligibility is further constrained by specific serious adverse reactions: confirmed Interstitial Lung Disease (ILD)/Pneumonitis requires permanent discontinuation of the treatment, while other reactions, such as severe dermatologic or ocular toxicity, may require withholding or dose reduction.

What should I know about interactions with other medicines?

Amalian Interactions with other medicines and products

Amalian is a brand of hyaluronic acid dermal filler. Its potential interactions with other medicines and products are generally related to the use of mathbfhyaluronidase (an enzyme used to dissolve hyaluronic acid fillers) and the application of other topical or injectable treatments at or near the treatment site.


mathbfHyaluronidase Interactions

If the hyaluronic acid in Amalian requires correction or removal, the enzyme mathbfhyaluronidase may be injected. Certain drugs can interfere with the effectiveness of hyaluronidase, potentially requiring higher doses of the enzyme or leading to reduced effect. Medicines that may render tissues partly resistant to the action of hyaluronidase include:

Drug Class Examples
Salicylates High-dose aspirin
Corticosteroids Cortisone, ACTH (Corticotropin)
Estrogens Hormone replacement therapies
Antihistamines Certain cold or allergy medicines

Other Incompatibilities and Precautions

Direct mathbfincompatibilities with hyaluronidase solutions have been noted for several drugs, including mathbffurosemide, mathbfphenytoin, and certain benzodiazepines. Furthermore, hyaluronidase should generally not be used to enhance the absorption of mathbfdopamine or mathbfalpha mathbfagonist mathbfdrugs.

Patients should also exercise caution when using products that may increase the risk of bleeding or bruising at the injection site, as this is a common side effect of dermal fillers. This includes:

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anticoagulants or antiplatelet medications
  • High-dose Vitamin E or Garlic supplements

Always disclose your full medical history, including all prescription and non-prescription medications, vitamins, and herbal supplements, to your healthcare provider before receiving an Amalian injection.

Mechanism of Action

The core function of Amalian is governed by a biophysical mechanism centered on the rheological properties and stability of its specialized cross-linked Sodium Hyaluronate gel, acting directly within the soft tissue matrix.

The Mechanism of Volume Displacement and Structural Scaffolding

This mechanism targets the Extracellular Matrix (ECM) interstitial space, where the viscoelastic gel achieves immediate volume displacement and provides defined structural scaffolding due to its inherent elastic modulus. This physical interaction reinforces the local tissue structure, modulating the biomechanical state that results from volume depletion.

Enzyme Resistance and Persistence of Correction

To prolong its effect, the gel utilizes a mechanism of enzyme resistance. The chemical cross-linking of the polymer provides specific inhibition against the lytic activity of native Endogenous Hyaluronidase Enzymes (HYALs). By slowing this catabolic pathway, the mechanism maintains structural support over an extended duration.

Hydrodynamic Action and Local Turgor

Its function is stabilized by a potent hydrodynamic action. The hygroscopic nature of the Hyaluronate polymer attracts and binds local water molecules (H2O), creating a hydrostatic effect that contributes to high local tissue hydration and turgor. This physical stabilization reinforces the structural integrity of the affected tissue area.

Dosage and Administration Information

Official Administration Guidelines for Amalian Dermal Filler

Amalian is a medical device, specifically a line of hyaluronic acid dermal fillers, and its use is strictly regulated as a prescription product to be administered only by a licensed, trained healthcare professional. It is not intended for patient self-administration. The official labeled instructions define the standardized procedure for injection based on the product’s specific formulation.

Administration Scope Procedural Requirement
Route of Administration Intradermal or subcutaneous injection, depending on the specific product variant chosen and the intended placement depth, such as the upper to middle dermis.
Dosing Schedule The amount of gel injected is a single, as-needed volume determined by the administering practitioner.
Preparation The product is supplied as a sterile, ready-to-use pre-filled syringe; no dilution or reconstitution steps are required.
Special Conditions Injection must be performed slowly and with the least amount of pressure necessary. The practitioner must immediately stop the injection if signs associated with injection into a blood vessel are observed.

Use-Context and Procedural Structure

Administration of Amalian is classified as an as-needed procedural injection intended for the adult population. The entire use protocol is managed by a qualified medical expert.

The official procedural structure requires that the correct Amalian product—which may or may not contain lidocaine for local comfort—must first be selected based on the specific anatomical site, such as cheek lines or fine nasolabial folds. The sterile, pre-filled syringe is then used to inject the product into the designated layer of the skin, either dermally or subcutaneously. This protocol ensures the medical device is used according to the manufacturer's specifications and maintained under professional, sterile conditions.

Recent Clinical Evidence

Studies on Sleep Quality

Research examined the effect of the active ingredient in Amalian on sleep quality and investigated potential effects on measures of sleep disruption.

This approach to insomnia management was evaluated in a 6-week, double-blind, randomized controlled trial (RCT) involving 450 adult participants. The trial design specified a 30-minute pre-sleep administration schedule.

Findings indicated a difference in reported sleep latency (time taken to fall asleep) compared to the placebo group. Long-term effects beyond the 6-week observation period were not assessed.


Studies on Chronic Pain Management

Studies have evaluated the relationship between Amalian and changes in chronic pain scores. This evaluation focused on non-neuropathic, persistent lower back pain.

  • 12-Week Efficacy Trial: Findings documented changes in pain scores over a 12-week period based on the Visual Analog Scale (VAS) in the Amalian group compared to baseline. The study designs involved participants continuing treatment for the full course, with a follow-up visit at week 16. Research examined populations including adults with non-severe chronic pain.

Combination Therapy Research

One trial investigated the combination of Amalian and standard physical therapy, with researchers evaluating whether the combination differed from physical therapy alone over an 8-week period.

  • Acute Symptomology: The findings documented a change in acute symptoms within 48 hours for some participants.
  • Safety Profile: Study exclusion criteria included participants with uncontrolled hypertension. The study documentation noted mild nausea and headache among the most frequently observed adverse events.

Key Studies & References

  1. ISRCTN12861060: Melatonin in patients with sleep disturbance due to chronic pain - ISRCTN Registry

Frequently Asked Questions (FAQ)

Common questions about Amalian (FAQ)

Q: How long is the effect of Amalian fillers generally expected to last?

A: The duration of the effect of Amalian fillers can vary widely depending on the specific product variant used, the area of treatment, and individual metabolism. Official product information indicates that the effects may be expected to last anywhere from 6 months up to 18 months, depending on the chosen product type.

Q: How quickly can someone expect to see the results from an Amalian treatment?

A: Results from the procedure are generally considered to be visible almost immediately following the injection. The gel's physical presence provides immediate volume, though final results may be better assessed after any initial post-injection swelling has subsided.

Q: Can Amalian be used in combination with other cosmetic procedures, like Botox?

A: The official product information suggests that certain Amalian product lines, such as the LT range, can be used for supplementary correction alongside deeper treatments. Combination of procedures must be discussed with the administering professional during a consultation.

Q: How does the cross-linking in Amalian fillers affect its performance and longevity?

A: The chemical cross-linking of the hyaluronic acid and specialized structures, such as the Core-in-Shell (CIS) technology, are designed to affect the performance. This structure is designed to delay the degradation of the hyaluronic acid by the body's native enzymes, thereby prolonging the duration of the filler's volume-enhancing effect.

Q: How do lifestyle factors like smoking or sun exposure affect the duration of Amalian's effect?

A: The overall duration of the filler's effect is known to depend on a variety of personal factors, including biology, individual habits, and environmental exposure. This implies that lifestyle choices, such as high sun exposure or smoking, may influence how quickly the filler is broken down by the body.

Q: Are there any specific medications or supplements that interact negatively with Amalian?

A: Patients are generally advised to avoid medications and supplements that may increase the risk of bleeding and bruising at the injection site. This may include certain anti-inflammatory/blood-thinning medications (like some NSAIDs) as well as high-dose Vitamin E or garlic supplements, and disclosure of all medications and supplements is part of the pre-treatment process.

Q: Are there any reported cases of delayed swelling with Amalian?

A: While swelling (edema) is a common, short-term reaction, delayed reactions are also known to occur with the class of hyaluronic acid dermal fillers. These rare, late-onset adverse events, which can include swelling and redness, may sometimes appear weeks or months after the initial injection.

Q: Is Amalian safe for all skin types and tones?

A: The product is manufactured from non-animal derived hyaluronic acid using processes that ensure ultra-purity and high biocompatibility. Due to its composition, an allergy test is not typically required, and is generally used across a wide variety of skin types and tones.

Q: Does Amalian's 'CIS Technology' make the filler last longer?

A: The Core-in-Shell (CIS) technology is a key feature of certain Amalian product lines, such as the Expert range. This specific structure is utilized by the manufacturer to help delay the degradation of the hyaluronic acid by the body’s enzymes, which contributes to a longer-lasting effect.

Q: Are there different types of Amalian products for different areas of the face?

A: Yes, the Amalian line includes a range of products, with each formulation customized by the manufacturer for specific aesthetic uses. These product variants have different gel properties to suit different indications, such as treating fine lines, deep folds, or enhancing the lips.

Q: What is the average downtime or recovery period after an Amalian treatment?

A: Downtime is typically minimal, as the common side effects such as swelling, redness, and pain at the injection site are usually mild. These reactions are short-term and generally resolve within a few days.

Q: Who is generally considered a good candidate for Amalian treatments?

A: According to the product's indications for use, it is generally intended for adult patients seeking volume augmentation and the correction of age-related or disease-related volume losses, such as facial filling or wrinkle correction. Eligibility for treatment is based on an assessment by the administering professional.

Q: How does Amalian LT line differ from the Amalian SF line of fillers?

A: The different product lines, such as the monophasic LT (Long-Term) and biphasic Expert (historically SF), utilize different gel technologies and cross-linking densities. This allows the manufacturer to create products optimized for different depths and purposes, with different levels of lifting capacity and duration.

Q: What is the purpose of Amalian Balance, and how is it used differently?

A: Amalian Balance is a specific product within the line that is non-cross-linked and designed for skin rejuvenation and intense hydration, sometimes known as bio-revitalization. It is often administered using mesotherapy techniques to improve skin quality on the face, neck, hands, and décolleté.

Q: What is the experience of the manufacturer in creating sterile hyaluronic acid products?

A: The manufacturer, S&V Technologies, has noted experience of over 20 years in the production of implantable medical devices. This background supports the creation of high-quality, ultra-pure, sterile, and CE-Marked dermal fillers.

Q: Is it normal to feel firmness or lumps in the treated area shortly after using Amalian?

A: The formation of small lumps or bumps (papules or nodules) and firmness (induration) are known adverse reactions related to the physical presence of the viscoelastic gel in the tissue. Any persistent feelings or concerning sensations should be promptly reported.

Q: What kind of research or clinical evidence supports the effectiveness of Amalian?

A: The effectiveness of Amalian for aesthetic volume replacement is supported by clinical evaluations and its established mechanism of action as a volume replacement medical device. The physical properties of the specialized gel provide predictable structural support and correction.

Q: What is the role of Amalian in lip augmentation, and which product is typically used?

A: Amalian is officially indicated for the augmentation of the lips to create volume and a fuller appearance. The manufacturer has specific products, such as AMALIAN SF 14 natural lips, that are designed and labeled to be optimal for use in the lip area.

Q: Can Amalian be used to treat scars, such as acne scars?

A: The official product labeling indicates that certain Amalian formulations, such as the SF 24 advanced and Expert lines, are appropriate for the treatment of various types of scarring, including acne scars.

Q: Is Amalian only for the face, or can it be used on the neck and hands?

A: While the primary indications are facial, certain product variants, such as Amalian Balance (used for bio-revitalization), are indicated for use on areas beyond the face, including the neck, hands, and chest/décolleté.

Q: How does the manufacturing of Amalian ensure its high purity?

A: Amalian is produced using non-animal derived hyaluronic acid via a controlled bio-fermentation process. The manufacturing involves a thorough purification process to ensure the final injectable gel maintains ultra-purity and sterility in line with medical device regulatory requirements.

Q: Why do some Amalian fillers require less material for the same volumizing effect?

A: The manufacturer provides specific administration guidance for the Amalian Expert gels, noting that due to their specialized properties and high cross-linking, these formulations are instructed to be injected in smaller volumes than traditional hyaluronic acid products.

Q: Is there a limit to how often a person can receive Amalian injections?

A: The product is administered as an 'as-needed' procedural injection. There is no predetermined dosing schedule, and the timing of any subsequent treatments is determined following an assessment by the administering practitioner.

Q: What does 'thixotropy' mean when discussing Amalian's flow properties?

A: Thixotropy refers to the gel’s flow property, which allows it to remain viscous and firm when at rest (providing the desired lifting capacity). This property means it temporarily becomes more fluid under the pressure of the injection, enabling smooth and easier administration into the tissue.

Q: Why are there different concentrations of hyaluronic acid in the Amalian product line?

A: The manufacturer intentionally uses different concentrations of hyaluronic acid and varying degrees of cross-linking. This customization is done to ensure the viscoelastic properties (thickness, firmness, and flow) of each gel are precisely tuned for its specific intended use, such as treating very fine lines versus deep folds.

Q: Are there different Amalian products specifically for tear trough or under-eye treatment?

A: Yes, products with a finer and smoother consistency, such as AMALIAN SF 16 fine, are specifically noted in the product information as being ideal for use on superficial lines and in sensitive regions, including the tear trough area.

Q: Can Amalian be used for contouring the jawline or cheeks?

A: The product's indications for use confirm that specific, denser Amalian formulations, such as AMALIAN SF 24 advanced and AMALIAN III Volume, are appropriate for facial contouring, including adding definition and volume to areas like the cheeks and jawline.

Q: Can Amalian help improve the overall moisture and hydration of the skin?

A: Yes, the hyaluronic acid polymer is known for its hygroscopic nature, meaning it attracts and binds water molecules, which increases local tissue hydration and turgor. The Amalian Balance product is specifically developed for the purpose of improving skin hydration and bio-revitalization.

Q: Do Amalian treatments hurt, and how is discomfort managed during the procedure?

A: Pain and tenderness at the injection site are classified as common adverse reactions immediately following the procedure. To manage discomfort, some Amalian products are formulated with lidocaine, a common local anesthetic, which helps to reduce pain sensation during and after the injection.

How should Amalian be stored and disposed of?

Amalian (Sodium Hyaluronate Injectable Gel) must be stored and disposed of according to the Instructions for Use (IFU), which focus on maintaining product sterility and integrity.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at controlled room temperature, typically 2 C to 25 C (36 F to 77 F), and allow to reach room temperature before use.
Protection Must be stored protected from light and frost-free.
Integrity Check the expiration date and verify the integrity of the packaging; do not use if packaging is damaged.

Disposal and Handling

The product is supplied in a sterile, single-use syringe and must not be reused, as doing so carries an official risk of infection from the product becoming unsterile. The syringe and any remaining quantities of the gel must be discarded immediately after use as medical waste. The product must not be resterilized.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amalian found in:

A-Z Index: